OAR: Orthopaedic Alliance Roundtable
A dynamic group of clinicians, regulators, researchers and industry representatives working within the orthopaedic ecosystem
Our mission – foster education, communication and shared expertise to provide timely and innovative solutions to challenges impacting the delivery of safe and effective orthopaedic treatments to patients.
High-Level OAR Strategic Priorities
Establish OAR as a Provisionally Approved CDRH Collaborative Community
Expand Use of RWD/RWE in the Orthopaedic Space
Optimize Availability of Anti-Infective Solutions for Orthopaedic Patients
Promote Innovation in International Consensus and Standards
Address New Regulatory/ Policy Needs for Novel Orthopaedic Technologies
Foster a Spirit of Simplicity
What Is a Collaborative Community?
A collaborative community is a continuing forum in which private- and public-sector members, which can include the FDA, work together on medical device challenges to achieve common objectives and outcomes. They are convened by interested stakeholders and may exist indefinitely, produce deliverables as needed, and tackle challenges with broad impacts. Collaborative communities may develop for a number of reasons, including when:
- Challenges are ill-defined or there is no consensus on the definition of the challenges
- Challenges and outcomes are complex
- Partners are interrelated
- Incremental or unilateral efforts to address the challenge have been ineffective
- Partners seek to optimize efforts, including preventing duplication of efforts
- Better outcomes could be achieved with integrating different perspectives, experiences, resources, and expertise.
For more information: Fostering Collaborative Communities to Improve Patient Healthcare (FDA Voices, December 4, 2018)
Members of a Collaborative Community
Collaborative communities typically include diverse, relevant organizations and individuals impacted by a specific topic. For example, patients and care-partners, academics, health care professionals, payers, federal and state agencies, international regulatory bodies, and industry may be engaged as part of a collaborative community.
Purpose of a Collaborative Community
Collaborative communities are equipped to perform activities such as:
- Developing best practices and robust strategies for addressing challenges
- Generating and evaluating evidence that supports novel approaches; and
- Disseminating and implementing solutions.
The communities may also work to clarify ill-defined challenges or generate consensus on the definition and scope of the challenge which will aid in tailoring appropriate strategies to tackle those challenges. By leveraging the wide variety of resources, power and expertise of the community members, collaborative communities can help address challenges and opportunities related to medical devices.
Collaborative Communities Toolkit
The Collaborative Communities Toolkit is a collection of materials that could help prospective communities in their development and effective collaboration, so that they are adequately prepared to take on health care challenges. Each component of this toolkit could help members of both new and existing communities work with one another.
Collaborative Communities with CDRH Participation
The FDA currently participates as a member of these collaborative communities, which have been established and are managed and controlled by external stakeholders.
- Updated 9-13-23
National Evaluation System for health Technology Coordinating Center (NESTcc) Collaborative CommunityExternal Link Disclaimer